These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20045672)

  • 21. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
    Fenouillet E; Miquelis R; Drillien R
    Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
    Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of an HIV cell-cell fusion assay by using two genetically modified HeLa cell lines and reporter gene.
    Sakamoto T; Ushijima H; Okitsu S; Suzuki E; Sakai K; Morikawa S; Müller WE
    J Virol Methods; 2003 Dec; 114(2):159-66. PubMed ID: 14625051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. d(TGGGAG) with 5'-nucleobase-attached large hydrophobic groups as potent inhibitors for HIV-1 envelop proteins mediated cell-cell fusion.
    Chen W; Xu L; Cai L; Zheng B; Wang K; He J; Liu K
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5762-4. PubMed ID: 21873060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccinia-based reporter gene cell-fusion assays to quantitate functional interactions of HIV envelope glycoprotein with receptors.
    Dey B; Berger EA
    Curr Protoc Immunol; 2003 May; Chapter 12():Unit 12.10. PubMed ID: 18432897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring viral-mediated membrane fusion using fluorescent reporter methods.
    Kondo N; Miyauchi K; Matsuda Z
    Curr Protoc Cell Biol; 2011 Mar; Chapter 26():Unit 26.9. PubMed ID: 21400700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual Split Protein (DSP) Assay to Monitor Cell-Cell Membrane Fusion.
    Nakane S; Matsuda Z
    Methods Mol Biol; 2015; 1313():229-36. PubMed ID: 25947669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel dual luciferase assay for the simultaneous monitoring of HIV infection and cell viability.
    Mitsuki YY; Yamamoto T; Mizukoshi F; Momota M; Terahara K; Yoshimura K; Harada S; Tsunetsugu-Yokota Y
    J Virol Methods; 2016 May; 231():25-33. PubMed ID: 26898957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tat-based cell-cell fusion method for screening HIV-1 fusion inhibitors].
    Wang X; Yang Y; Shen S; Wang X; Feng T; Hu Q; Zeng Y
    Sheng Wu Gong Cheng Xue Bao; 2018 Mar; 34(3):429-439. PubMed ID: 29577693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A high throughput Cre-lox activated viral membrane fusion assay identifies pharmacological inhibitors of HIV entry.
    Esposito AM; Cheung P; Swartz TH; Li H; Tsibane T; Durham ND; Basler CF; Felsenfeld DP; Chen BK
    Virology; 2016 Mar; 490():6-16. PubMed ID: 26803470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Quantitative Fusion Assay to Study Measles Virus Entry.
    Navaratnarajah CK
    Methods Mol Biol; 2024; 2808():1-7. PubMed ID: 38743358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sphingomyelin synthase 2, but not sphingomyelin synthase 1, is involved in HIV-1 envelope-mediated membrane fusion.
    Hayashi Y; Nemoto-Sasaki Y; Tanikawa T; Oka S; Tsuchiya K; Zama K; Mitsutake S; Sugiura T; Yamashita A
    J Biol Chem; 2014 Oct; 289(44):30842-30856. PubMed ID: 25231990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How entry inhibitors synergize to fight HIV.
    Melikyan GB
    J Biol Chem; 2017 Oct; 292(40):16511-16512. PubMed ID: 28986430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 entry and how to block it.
    Brelot A; Alizon M
    AIDS; 2001; 15 Suppl 5():S3-11. PubMed ID: 11816172
    [No Abstract]   [Full Text] [Related]  

  • 35. Dynamin-2 Stabilizes the HIV-1 Fusion Pore with a Low Oligomeric State.
    Jones DM; Alvarez LA; Nolan R; Ferriz M; Sainz Urruela R; Massana-Muñoz X; Novak-Kotzer H; Dustin ML; Padilla-Parra S
    Cell Rep; 2017 Jan; 18(2):443-453. PubMed ID: 28076788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viral entry denied.
    Doms RW
    N Engl J Med; 2004 Aug; 351(8):743-4. PubMed ID: 15317885
    [No Abstract]   [Full Text] [Related]  

  • 37. Fusion mediated by the HIV-1 envelope protein.
    McManus CM; Doms RW
    Subcell Biochem; 2000; 34():457-81. PubMed ID: 10808341
    [No Abstract]   [Full Text] [Related]  

  • 38. Lung cell entry, cell-cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75.
    Arora P; Nehlmeier I; Kempf A; Cossmann A; Schulz SR; Dopfer-Jablonka A; Baier E; Tampe B; Moerer O; Dickel S; Winkler MS; Jäck HM; Behrens GMN; Pöhlmann S; Hoffmann M
    Lancet Infect Dis; 2022 Nov; 22(11):1537-1538. PubMed ID: 36116462
    [No Abstract]   [Full Text] [Related]  

  • 39. Response: HIV Fusion.
    Weiss RA
    Science; 1996 Sep; 273(5282):1643. PubMed ID: 17835034
    [No Abstract]   [Full Text] [Related]  

  • 40. HIV Fusion.
    Bristow CL
    Science; 1996 Sep; 273(5282):1642b-3b. PubMed ID: 17835033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.